Related Experiment Video
Updated: Nov 22, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Abstract:
A year after study results were initially reported, the antibody-drug conjugate trastuzumab deruxtecan continues to show strong activity in patients with advanced HER2-positive breast cancer: In a phase II trial, the agent elicited a high overall response rate and long median progression-free survival-as well as early, but promising, overall survival results.
More Related Videos
13:43Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models
Published on: April 1, 2022
07:45Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Overview and Classification
Tumor Immunotherapy